Spiramycin

# Spiramycin ## Overview - **Classification**: Macrolide antibiotic (16-membered ring macrolide). - **Mechanism**: Inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, leading to bacteriostatic effects. ## Primary Indications 1. **Toxoplasmosis**: Especially for prevention of mother-to-child transmission in pregnancy. 2. **Cryptosporidiosis**: Management of symptoms, particularly in immunocompromised patients. 3. **Dental/Oral Infections**: As an alternative in penicillin-allergic patients (less common). ## Adult Dosing ### Standard Dosing **Toxoplasmosis in Pregnancy (Prevention of Congenital Transmission)** - **Dose**: **3 million IU** (approx. 1 gram) - **Frequency**: Every 8 hours (TID) - **Route**: Oral - **Duration**: Throughout pregnancy if maternal infection is confirmed, or until fetal infection is ruled out. **General Infections (e.g., Dental, Soft Tissue - if indicated)** - **Dose**: **1.5 million IU** to **3 million IU** (approx. 0.5 to 1 gram) - **Frequency**: Every 8 hours (TID) - **Route**: Oral - **Duration**: 5-7 days, or as clinically indicated. ### Dose Adjustments - **Renal Impairment**: No specific dose adjustment is generally needed. Primarily excreted via bile. - **Hepatic Impairment**: Use with caution in severe impairment. Monitor liver function. Dose reduction may be considered, but specific guidelines are limited. - **Elderly Patients**: No specific dose adjustment based on age alone. Consider hepatic/renal status if compromised. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: Limited data for routine infections. - **Special Notes**: Not typically a first-line agent. For congenital toxoplasmosis, pyrimethamine/sulfadiazine is usually preferred for treatment in the infant. Consult specialist. ### Infants (1-12 months) - **Dose**: **50-100 mg/kg/day** (or **150,000-300,000 IU/kg/day**) - **Frequency**: Divided into 2-3 doses - **Maximum**: **1.5 million IU/day** (or **500 mg/day**) ### Children (1-12 years) - **Dose**: **50-100 mg/kg/day** (or **150,000-300,000 IU/kg/day**) - **Frequency**: Divided into 2-3 doses - **Maximum**: **3 million IU/day** (or **1 gram/day**) ### Adolescents (13-18 years) - **Dose**: Adult dosing typically applies. - **Maximum**: **6 million IU/day** (or **2 grams/day**). ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to spiramycin or other macrolides. - **Absolute**: Concomitant use with ergot alkaloids (e.g., ergotamine, dihydroergotamine) due to risk of ergotism. ### Common Adverse Effects - **Common (1-10%)**: Nausea, vomiting, diarrhea, abdominal pain. - **Common (1-10%)**: Indigestion, taste disturbances. - **Serious but Rare**: Allergic reactions (rash, angioedema), hepatotoxicity (elevated LFTs, cholestatic jaundice), QT prolongation (less common than with erythromycin). ### Key Drug Interactions - **Ergot Alkaloids (e.g., ergotamine)**: Increased risk of ergotism. **Avoid concomitant use.** - **Warfarin**: May potentiate anticoagulant effect, increasing INR. **Monitor INR closely.** - **Theophylline**: Possible increase in theophylline levels. **Monitor levels if co-administered.** - **Levodopa**: Reduced carbidopa absorption, lowering levodopa plasma levels. **Monitor clinical response.** ## Monitoring & Follow-up - **Before Treatment**: Baseline liver function tests (LFTs) if hepatic impairment suspected. - **During Treatment**: Monitor for gastrointestinal side effects. Periodic LFTs for prolonged therapy or hepatic impairment. - **Clinical Signs**: Watch for signs of allergic reaction (rash, itching), persistent severe GI upset, or jaundice. ## Clinical Pearls - 💡 **Tip 1**: Spiramycin is preferred for **toxoplasmosis in pregnancy** due to its good placental penetration and lower fetal toxicity profile. - 💡 **Tip 2**: Can be taken with or without food. Administer with a full glass of water. - 💡 **Tip 3**: Compared to other macrolides (e.g., erythromycin), spiramycin has a **lower potential for significant CYP3A4-mediated drug interactions**. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.